Table 3.

Characteristics of hospitalized patients.

		Disease Severity
	Overall	Moderate	Severe
Characteristic	106	67	39
Admitted from, No. (%)
Home	90 (84.9)	58 (86.6)	32 (82.1)
Skilled nursing facility/rehab	10 (9.4)	5 (7.5)	5 (12.8)
Hospital Transfer	3 (2.8)	2 (3.0)	1 (2.6)
Other	3 (2.8)	2 (3.0)	1 (2.6)
Vital signs on ED admission, median (IQR)
Temperature, median (IQR), °F	99 [98, 100]	99 [98, 100]	98 [98, 100]
Heart rate, beats/min	104 [85, 116]	101 [82, 112]	109 [95, 118]
Respiratory rate, breaths/min	20 [18, 24]	20 [18, 24]	21 [20, 24]
Oxygen saturation, %	94 [91, 97]	94 [91, 98]	94 [80, 96]
Highest level of respiratory intervention, No. (%)
Nasal cannula	30 (28.3)	26 (38.8)	4 (10.3)
Non-rebreather	17 (16.0)	11 (16.4)	6 (15.4)
High-flow nasal cannula	13 (12.3)	5 (7.5)	8 (20.5)
BiPAP	4 (3.8)	0 (0.0)	4 (10.3)
Invasive mechanical ventilation	13 (12.3)	0 (0.0)	13 (33.3)
Complications, No. (%)
Multiorgan failure	9 (8.5)	0 (0.0)	9 (23.1)
Pulmonary complications	66 (62.3)	33 (49.3)	33 (84.6)
Cardiovascular complications	16 (15.1)	3 (4.5)	13 (33.3)
Renal failure	21 (19.8)	8 (11.9)	13 (33.3)
Sepsis	12 (11.3)	4 (6.0)	8 (20.5)
Bleeding	3 (2.8)	3 (4.5)	0 (0.0)
Treatments, No. (%)
Chloroquine	1 (0.5)	1 (1.5)	0 (0.0)
Hydroxychloroquine	53 (27.5)	32 (47.8)	19 (48.7)
Azithromycin	47 (24.4)	25 (37.3)	18 (46.2)
Corticosteroids	6 (3.1)	2 (3.0)	3 (7.7)
Tocilizumab	3 (1.6)	3 (4.5)	0 (0.0)
Plasma from recovered individuals	5 (2.6)	3 (4.5)	2 (5.1)
Anticoagulation	19 (9.8)	9 (13.4)	9 (23.1)
Clinical outcome at data cutoff, No. (%)
Fully recovered	48 (45.3)	47 (70.1)	1 (2.6)
Recovered with complications	14 (13.2)	12 (17.9)	2 (5.1)
Ongoing infection	10 (9.4)	8 (11.9)	2 (5.1)
Died of COVID-19 related complications	34 (32.1)	0 (0.0)	34 (87.2)